NASDAQ: KLTO
Klotho Neurosciences Inc Stock Ownership - Who owns Klotho Neurosciences?

Insider buying vs selling

Have Klotho Neurosciences Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when KLTO insiders and whales buy or sell their stock.

KLTO Shareholders

What type of owners hold Klotho Neurosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Joseph Sinkule6.68%4,846,700$1.50MInsider
Redwoods Capital LLC4.29%3,115,000$965.65kInsider
Chardan Capital Markets LLC1.77%1,284,364$398.15kInsider
Jeff Leblanc1.27%920,342$285.31kInsider
Samuel M. Zentman1.02%736,440$228.30kInsider
Vanguard Group Inc0.81%588,342$182.39kInstitution
Shalom Hirschman0.77%558,873$173.25kInsider
Geode Capital Management LLC0.45%323,927$100.42kInstitution
Northern Trust Corp0.30%218,785$67.82kInstitution
State Street Corp0.27%196,400$60.88kInstitution

1 of 3

KLTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KLTO2.52%16.11%
LIXT7.39%92.61%
NEUP2.77%97.23%Net Buying
JUNS3.95%32.80%Net Buying
CASI3.18%96.82%

Klotho Neurosciences Stock Ownership FAQ

Who owns Klotho Neurosciences?

Klotho Neurosciences (NASDAQ: KLTO) is owned by 2.52% institutional shareholders, 16.11% Klotho Neurosciences insiders, and 81.38% retail investors. Joseph Sinkule is the largest individual Klotho Neurosciences shareholder, owning 4.85M shares representing 6.68% of the company. Joseph Sinkule's Klotho Neurosciences shares are currently valued at $1.42M.

If you're new to stock investing, here's how to buy Klotho Neurosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.